Clinical trials
Phase 2 Primary Myelofibrosis trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Completed | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karyopharm Therapeutics Inc | 2 |
| GlaxoSmithKline | 1 |
| Incyte Corporation | 1 |
| Kartos Therapeutics, Inc. | 1 |
| NS Pharma, Inc. | 1 |
| Ryvu Therapeutics SA | 1 |
| Telios Pharma, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 8 |
| Mastocytosis, Systemic | 1 |
| Myeloproliferative Disorders | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Polycythemia Vera | 1 |
| Thrombocytopenia | 1 |
| Thrombocytosis | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.